Action 300841 CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Chengdu Kanghua Biological Products Co., Ltd.

Actions

300841

CNE100003Y57

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 07/06/2024 		Varia. 5j. Varia. 1 janv.
55,05 CNY -0,60 % Graphique intraday de Chengdu Kanghua Biological Products Co., Ltd. -4,92 % -29,00 %
23/04 La société Chengdu Kanghua Biological Products Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024 CI
29/03 La société Chengdu Kanghua Biological Products Co. publie ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Chengdu Kanghua Biological Products Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 08 May 2024
Chengdu Kanghua Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Chengdu Kanghua Biological Products Co., Ltd. Proposes Final Cash Dividend for the Year 2023
Tranche Update on Chengdu Kanghua Biological Products Co., Ltd.'s Equity Buyback Plan announced on January 23, 2024.
Chengdu Kanghua Biological Products Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Chengdu Kanghua Biological Products Co., Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.
Chengdu Kanghua Biological Products Co., Ltd. authorizes a Buyback Plan.
Kanghua Biological Products Licenses Norovirus Vaccine to HilleVax
Hillevax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of China
Chengdu Kanghua Biological Products Co., Ltd.(SZSE:300841) dropped from Shenzhen Stock Exchange Component A Share Index
Chengdu Kanghua Biological Products Co., Ltd.(SZSE:300841) dropped from Shenzhen Stock Exchange Component Index
Jinan Kangyue Qiming Investment Partnership (Limited Partnership) completed the acquisition of 7.4% stake in Chengdu Kanghua Biological Products Co., Ltd. from Aokang Group Co., Ltd. and Wang Zhentao.
Chengdu Kanghua Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Jinan Kangyue Qiming Investment Partnership (Limited Partnership) agreed to acquire 7.4% stake in Chengdu Kanghua Biological Products Co., Ltd. from Aokang Group Co., Ltd. and Wang Zhentao for approximately CNY550 million.
Chengdu Kanghua Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Certain A Shares of Chengdu Kanghua Biological Products Co., Ltd. are subject to a Lock-Up Agreement Ending on 16-JUN-2023.
Chengdu Kanghua Biological Products Co., Ltd. Approves Cash Dividend for 2022, Payable on 24 May 2023
Chengdu Kanghua Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Chengdu Kanghua Biological Products Co., Ltd. Proposes Final Cash Dividend for the Year of 2022
Tranche Update on Chengdu Kanghua Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 29, 2021.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 300841
  4. Actualités Chengdu Kanghua Biological Products Co., Ltd.
  5. Autres langues